Lupin Builds Momentum As It Anticipates FDA Action On Spiriva Rival

Recent Boosts Also Include EIR For Nagpur Plant As Well As US Lurasidone Launch

 
• By David Wallace
  
Newton's Cradle with red ball
Action on Lupin’s Spiriva generic is expected to add to US momentum • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business